ETRAVIRINE 200 mg/1
ETRAVIRINE · TABLET · Leading Pharma, LLC
No Recall History
Plain English
Etravirine is an oral tablet used to treat HIV-1 infection as part of combination antiretroviral therapy. It works by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate in the body.
Key Facts
- Brand Name
- ETRAVIRINE
- Generic Name
- ETRAVIRINE
- NDC Code (Product)
69315-286- Manufacturer
- Leading Pharma, LLC
- Strength
- 200 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA215402
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 06/05/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is ETRAVIRINE used for?
Etravirine is an oral tablet used to treat HIV-1 infection as part of combination antiretroviral therapy. It works by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate in the body.
Is ETRAVIRINE a controlled substance?
ETRAVIRINE is not classified as a controlled substance by the DEA.
What is the generic name for ETRAVIRINE?
The generic name for ETRAVIRINE is ETRAVIRINE. There are 9 other brand versions of ETRAVIRINE.
What is the NDC code for ETRAVIRINE 200 mg/1?
The NDC (National Drug Code) for ETRAVIRINE 200 mg/1 is 69315-286, listed by Leading Pharma, LLC.